Clinical trials
Multiple Myeloma trials with no applicable phase and unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 3 |
| 2014 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 5 |
| 2021 | 3 |
| 2022 | 8 |
| 2023 | 3 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 36 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hebei Senlang Biotechnology Inc., Ltd. | 2 |
| Academic Centre for Dentistry in Amsterdam | 1 |
| Alberta Health Services, Calgary | 1 |
| Asan Medical Center | 1 |
| Assiut University | 1 |
| Bioray Laboratories | 1 |
| Central Hospital, Nancy, France | 1 |
| Chen Wenming | 1 |
| Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 1 |
| Federal University of Health Science of Porto Alegre | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 36 |
| Lymphoma | 7 |
| Hematologic Neoplasms | 5 |
| Leukemia | 4 |
| Hodgkin Disease | 3 |
| Lymphoma, Non-Hodgkin | 3 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Leukemia, Plasma Cell | 2 |
| Myeloproliferative Disorders | 2 |
| Neoplasms, Plasma Cell | 2 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.